Ardent Health disclosed that former CEO Martin Bonick, who left his roles on June 2, signed a separation agreement on June 26. The deal provides severance consistent with a no-cause termination, and sets out how his equity awards will be handled. He also agreed to 12-month non-compete and non-solicitation clauses.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ARDENT HEALTH INC (ARDT)?

Major stakeholders currently include Chai Trust Co LLC ($661.2M), Ventas, Inc. ($80.0M), Goldentree Asset Management LP ($19.7M). Based on the latest 13F filings, there are a total of 136 tracked investment funds and institutions maintaining positions in ARDT.

What is the overall institutional sentiment toward ARDT recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $33.4M, driven by 76 managers accumulating shares while 57 reduced their exposure.

Which institutions have been selling or reducing their ARDT positions?

In the latest period, 38 funds trimmed their holdings, and 19 managers completely exited their positions. The aggregate reported sell value was $74.1M.

Are there any notable investors adding ARDT to their portfolios?

Yes, buying activity remains notable. 26 institutions opened new positions in {ticker}, and 50 existing holders added to their shares. The total reported buy value for the quarter amounted to $88.1M.